Conversations in Drug Development Trends

APRIL 15, 2024

As the clinical research landscape continually evolves, the choice of a Contract Research Organization (CRO) partner can significantly impact the success of drug development programs. The post Reimagining CRO Partnerships: The Emerging Preference for Midsize Organizations appeared first on Worldwide Clinical Trials.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Research Pharmaceutical Companies 52

PPD

JULY 16, 2024

Download the white paper The post Expert Interpretation and Analysis of Regulatory Intelligence Are Key to FSP-Delivered Pharmacovigilance appeared first on PPD. We stand in contrast to providers that simply redistribute regulatory data obtained from regulatory authority websites and commercial sources.

Compliance 98

Compliance Regulations Production Trials 98

The Pharma Data

OCTOBER 27, 2020

“The MassARRAY SARS-CoV-2 Panel is the only assay on the market with 5 viral genome targets multiplexed into a single reaction, making it robust against potential mutations arising in the viral genome,” said Dr. Darryl Irwin , Vice President of Scientific Affairs. View original content to download multimedia: [link].

Pharmacogenetics 52

Pharmacogenetics Laboratories Clinical Research FDA 52

The Pharma Data

DECEMBER 21, 2020

” Kaiser Permanente’s elimination of member out-of-pocket costs applies to all fully insured benefit plans, in all markets, unless prohibited or modified by law or regulation. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. Source link.

Virus 52

Virus Clinical Research Treatment Disease 52

PPD

OCTOBER 2, 2024

Efficient and effective clinical operations are the backbone of successful clinical trials, and today’s biopharmaceutical, biotech and medical device organizations have a range of options to meet their needs in this critical area.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Research Trials 52

PPD

JULY 9, 2024

Biotech and biopharma companies, however, must do all of this in the face of wildly fluctuating workloads — particularly during the post-marketing phase. Download our white paper The post FSP Flex Hub Teams Maximize Efficiency Across Lifecycle Maintenance appeared first on PPD. However, completing this work is only half the challenge.

Compliance 52

Compliance Production Clinical Research Marketing 52

Conversations in Drug Development Trends

MARCH 7, 2024

Are there differential financial incentives to encourage sponsors to initiate early phase clinical research under a CTA, and how do those incentives compare to incentives that exist to initiate the same research under an IND? For additional insights, download our full white paper, “ First-in-Human Studies: IND or CTA? ”.

Clinical Trials 52

Clinical Trials Trials FDA Drug Development 52

PPD

NOVEMBER 21, 2023

The drug development industry is constantly adapting and evolving to bring novel therapeutics to market to improve the lives of patients across the globe. The results of this year’s survey reveal the latest trends in the clinical development industry and participants’ predictions for its future. Furthermore,

Clinical Development 52

Clinical Development Clinical Trials Trials Clinical Research 52

PPD

OCTOBER 12, 2023

There are over 2,000 CGTs currently being evaluated in clinical trials, with more than 200 in Phase III and 10-20 per year estimated to come to market by 2025. DOWNLOAD OUR WHITE PAPER Learn more about how PPD® Laboratory services can enhance your CGT projects.

Laboratories 52

Laboratories Clinical Trials Protein Expression Pharmacokinetics 52

The Pharma Data

MAY 6, 2021

myDiabby Healthcare and Roche – to advance connected solutions and streamline care for people living with diabetes in markets outside of the United States. View original content to download multimedia: [link]. Glooko Inc. “People with diabetes need access to all of the key information about their condition. About Glooko Inc.

International 52

International Therapies Disease Production 52

PPD

JUNE 17, 2024

For a developer using an FSO model but looking to evolve the way they undertake clinical trials, a bespoke FSP/FSO hybrid solution can provide a smooth transition to FSP outsourcing. This approach enables unbroken continuity of support and resources across clinical trial operations.

Clinical Trials 52

Clinical Trials Clinical Development Trials International 52

Alta Sciences

DECEMBER 31, 2024

One of the most important factors to consider during the course of your early-phase clinical research is drug-drug interactions (DDIs), which occurs when one drug alters the effect of another, either by reducing its effectiveness or elevating systemic concentrations to potentially dangerous levelsultimately causing side effects.

Therapies 52

Therapies Pharmacokinetics Pharmacogenetics Clinical Trials 52

Agency IQ

APRIL 8, 2024

Since these issues could occur during the investigational phase of clinical development as well as in the post-marketing setting—and product status could very well differ by country/region—ICH members determined that these guidelines should be developed to facilitate the exchange of information in both settings.

FDA 40

FDA Production Regulations Vaccine 40

The Pharma Data

DECEMBER 15, 2020

It is funded by the world’s leading charities dedicated to diabetes research, JDRF, and Diabetes UK, guided by both organizations’ strong commitment to facilitate deep interrogation of consolidated community-wide trial data as a means to accelerate clinical research and therapeutic development for T1D.

Drug Development 40

Drug Development Clinical Trials Trials Vaccine 40

The Pharma Data

SEPTEMBER 11, 2020

Covid-19 command center aims to accelerate clinical research by individual sponsors to combat disease. The Covid-19 command center is customized to meet immediate needs related to research on the novel coronavirus, but can also be used more broadly for other infectious disease clinical development efforts now and in the future.”.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Hospitals 52

PPD

NOVEMBER 25, 2024

Clinical trials are critical for advancing medical research and bringing new treatments to market. As the clinical trials landscape continues to evolve toward increased complexity, greater efficiency and accelerated development timelines, the ability to manage and optimize site performance has become even more critical.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

PPD

NOVEMBER 4, 2024

The PPD clinical research business of Thermo Fisher Scientific has conducted a comprehensive survey involving 150 drug developers from around the world. This year’s findings reveal a nuanced landscape where rising clinical trial costs, complex protocol designs and patient recruitment issues have emerged as significant challenges.

Drug Development 52

Drug Development Clinical Trials Clinical Research Trials 52

PPD

JANUARY 21, 2025

To better understand current challenges and their impact, the PPD clinical research business of Thermo Fisher Scientific surveyed global drug developers on the current state of the industry. This optimization reduces waste and accelerates time-to-market, allowing savings to be reinvested into additional trials or extended studies.

Clinical Trials 52

Clinical Trials Trials Clinical Research Drug Development 52

PPD

NOVEMBER 18, 2024

FSP experts at the PPD clinical research business of Thermo Fisher Scientific are experienced across the PV life cycle to truly and effectively “master the flow of regulatory change,” and many are native speakers who can navigate regulatory complexities for their geographic location.

Clinical Trials 52

Clinical Trials Regulations Compliance Production 52

Drug & Device Law

JULY 31, 2023

no[r] a marketing product” under Lanham Act). Leading Market Technologies, Inc. , 2016) (applying Georgia law), held that digital marketing software was “a service and not a product.” Gray Loon Outdoor Marketing. Paragon 28, Inc. 2019 WL 4751807, at *8 (D. 30, 2019) (“a patent application is not a tangible good. . .

Production 52

Production Trials International Government 52